This contract involves the delivery of fibrinogen concentrate to ensure continuous treatment for patients suffering from fibrinogen deficiency, a crucial blood clotting factor. The concentrate will be supplied to designated Regional Blood Donation and Transfusion Centers as specified by the National
Tender closed on 22 May 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, NATIONAL BLOOD CENTER has awarded 3 contracts to 3 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the delivery of fibrinogen concentrate to ensure continuous treatment for patients suffering from fibrinogen deficiency, which is a blood clotting factor. The concentrate will be supplied to designated recipients, specifically the Regional Blood Donation and Blood Treatment Ce
This contract involves the production and delivery of promotional materials aimed at healthcare entities and diagnostic laboratories as part of educational initiatives. The required printed materials include: 510 posters, 18,900 patient leaflets, 5,200 staff leaflets, and 1,260 informational badges/
This contract involves the delivery of Prothrombin Complex Concentrate (PCC) to ensure continuous treatment for patients with prothrombin complex factor deficiencies. The PCC, classified as a prescription medication, will be supplied to designated recipients, specifically the Regional Blood Donation
This contract involves the delivery of human coagulation factor VIII concentrate containing von Willebrand factor. The purpose is to ensure continuous treatment for patients with von Willebrand disease, with a required ratio of at least 1 unit of von Willebrand factor to 1 unit of factor VIII. Suppl
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
MMUH seeks a dermatology service provider to help meet increased demand for dermatological care through outsourced clinical services.
Market engagement opportunity to provide input on capillary blood sampling device requirements for HSCNI Trusts; questionnaire submissions due by 14th November 2026.
Hull City Council seeks to award a £187,500 Drug and Alcohol Treatment and Recovery services contract from November 2026 to March 2029 via direct award; providers must submit representations by 27 October 2026.
